Kimberly-Clark Completes Acquisition of Kenvue

• Kimberly-Clark completed the acquisition of Kenvue on Monday, nearly a year after the deal was first announced.
• The enterprise value of Kenvue was approximately $48.7 billion at the time of the acquisition.
• Kenvue is known for its consumer healthcare products, including Tylenol.
• Kimberly-Clark plans to improve growth and earnings following the acquisition.
• The acquisition was one of the largest of 2026.